triphosphoric acid has been researched along with s 8932 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Hu, WJ; Liu, J; Shen, JS; Tan, B; Wang, X; Xie, YC; Yang, Y | 1 |
| Tsuji, M | 1 |
2 other study(ies) available for triphosphoric acid and s 8932
| Article | Year |
|---|---|
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Kidney; Liver; Lung; Male; Mice; Nucleosides; Nucleotides; Polyphosphates; SARS-CoV-2; Tissue Distribution | 2021 |
Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19 Drug Treatment; Cryoelectron Microscopy; Humans; Molecular Docking Simulation; Nucleosides; Polyphosphates; Pyrazines; Reproduction; Ribonucleosides; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2 | 2022 |